×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: PSP Ferroptosis and Iron-Dependent Cell Death
mechanism
2,954 words
KG: ent-dise-bfd8f32d
2026-04-01
kind:mechanism
section:mechanisms
state:published
neurological:psp
cellular:cell-death
molecular:iron-metabolism
Contents
PSP Ferroptosis and Iron-Dependent Cell Death
⚙
Mechanism Info
Name
PSP Ferroptosis and Iron-Dependent Cell Death
Summary
Mechanistic page covering ferroptosis, iron-dependent lipid peroxidation, and regulated cell death in progressive supranuclear palsy
Knowledge Graph
Related Hypotheses (29)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
Transglutaminase-2 Cross-Linking Inhibition Strategy
Score: 0.49
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.45
Extracellular Matrix Stiffness Modulation
Score: 0.43
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor
Score: 0.42
Glial Glycocalyx Remodeling Therapy
Score: 0.41
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.37
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.47
Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55
Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Pri
Score: 0.51
ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drive
Score: 0.51
Dual-Circuit Tau Vulnerability Cascade
Score: 0.50
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
RAB27A-dependent extracellular vesicle engineering for mitoc
Score: 0.41
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.41
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.38
Show 24 more
Related Analyses (30)
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Show 25 more
Related Experiments (22)
s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.40
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
S-equol-induced ferroptosis mechanism in TNBC cells
exploratory · proposed · Score: 0.90
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
Peroxisome Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
Show 17 more
See Also (15)
Geniposide for Alzheimer's disease - immune biomarker t
mechanism · Pages share 5 hypotheses
Rotigotine and Rivastigmine Combination Therapy for Alz
clinical · Pages share 5 hypotheses
A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 5 hypotheses
Synaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 5 hypotheses
ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 4 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 4 hypotheses
Show 10 more